Bravecto for Dogs - 12-week dose (Rx)
Bravecto for Dogs - 12-week dose (Rx)
medication information
How to get prescriptions from Dutch online vets
Pick a plan and become a member
Schedule a call with a licensed vet
Order the prescriptions the vet recommends
Get unlimited care & follow-ups
Safety Information
Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Adverse events have been reported following use of isoxazoline drugs in breeding females. Before use in breeding female dogs, prescribing vets should refer to Post-Approval Experience and Animal Safety sections. Bravecto has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Bravecto is not effective against Amblyomma americanum ticks beyond 8 weeks after their first dose.1
Warnings
Keep Bravecto in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.1
Human Warnings
Bravecto is not for human use. Keep this and all drugs out of the reach of children. Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product. Do not eat, drink or smoke while handling the product. Wash hands thoroughly with soap and water immediately after use of the product.1
References
"Bravecto® Chew for Dogs." Merck Animal Health, Merck & Co., Inc., www.merck-animal-health-usa.com/bravecto/chew-for-dogs.